{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T15:53:41Z","timestamp":1791993221844,"version":"4.4.0"},"reference-count":25,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,1,11]],"date-time":"2025-01-11T00:00:00Z","timestamp":1736553600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100007634","name":"Ida Montinin S\u00e4\u00e4ti\u00f6","doi-asserted-by":"publisher","award":["20230116"],"award-info":[{"award-number":["20230116"]}],"id":[{"id":"10.13039\/100007634","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005609","name":"University of Turku","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100005609","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100009420","name":"Hospital District of Southwest Finland","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100009420","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","internationaljournalofcardiology.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Cardiology"],"published-print":{"date-parts":[[2025,3]]},"DOI":"10.1016\/j.ijcard.2025.132986","type":"journal-article","created":{"date-parts":[[2025,1,11]],"date-time":"2025-01-11T11:29:41Z","timestamp":1736594981000},"page":"132986","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"special_numbering":"C","title":["Impact of high bleeding risk and associated risk factors on major adverse cardiovascular or cerebrovascular events in primary percutaneous coronary intervention treated ST-elevation myocardial infarction"],"prefix":"10.1016","volume":"422","author":[{"given":"Henri","family":"Kesti","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kalle","family":"Mattila","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samuli","family":"Jaakkola","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joonas","family":"Lehto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nea","family":"S\u00f6derblom","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kalle","family":"Kalliovalkama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pekka","family":"Porela","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijcard.2025.132986_bb0005","doi-asserted-by":"crossref","first-page":"3720","DOI":"10.1093\/eurheartj\/ehad191","article-title":"2023 ESC guidelines for the management of acute coronary syndromes","volume":"44","author":"Byrne","year":"2023","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.ijcard.2025.132986_bb0010","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1161\/CIRCULATIONAHA.119.040167","article-title":"Defining high bleeding risk in patients undergoing percutaneous coronary intervention","volume":"140","author":"Urban","year":"2019","journal-title":"Circulation"},{"key":"10.1016\/j.ijcard.2025.132986_bb0015","doi-asserted-by":"crossref","DOI":"10.1093\/eurheartj\/ehae462","article-title":"Long-term outcomes of high bleeding risk patients undergoing percutaneous coronary intervention: a Korean nationwide registry","author":"Kang","year":"2024","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.ijcard.2025.132986_bb0020","doi-asserted-by":"crossref","first-page":"2711","DOI":"10.1016\/j.jacc.2020.03.070","article-title":"Validation of the academic research consortium high bleeding risk definition in contemporary PCI patients","volume":"75","author":"Cao","year":"2020","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.ijcard.2025.132986_bb0025","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1007\/s11239-021-02534-z","article-title":"Performance of the academic research consortium high-bleeding risk criteria in patients undergoing PCI for acute myocardial infarction","volume":"53","author":"Nicolas","year":"2022","journal-title":"J. Thromb. Thrombolysis"},{"key":"10.1016\/j.ijcard.2025.132986_bb0030","doi-asserted-by":"crossref","first-page":"371","DOI":"10.4244\/EIJ-D-20-00052","article-title":"Validation of the academic research consortium for high bleeding risk (ARC-HBR) criteria in patients undergoing percutaneous coronary intervention and comparison with contemporary bleeding risk scores","volume":"16","author":"Ueki","year":"2020","journal-title":"EuroIntervention"},{"key":"10.1016\/j.ijcard.2025.132986_bb0035","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1093\/eurheartj\/ehy462","article-title":"Fourth universal definition of myocardial infarction (2018)","volume":"40","author":"Thygesen","year":"2019","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.ijcard.2025.132986_bb0040","doi-asserted-by":"crossref","first-page":"1468","DOI":"10.1016\/j.jacc.2020.06.085","article-title":"Trial design principles for patients at high bleeding risk undergoing PCI: JACC scientific expert panel","volume":"76","author":"Capodanno","year":"2020","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.ijcard.2025.132986_bb0045","doi-asserted-by":"crossref","first-page":"2192","DOI":"10.1093\/eurheartj\/ehy223","article-title":"Standardized end point definitions for coronary intervention trials: the academic research consortium-2 consensus document","volume":"39","author":"Garcia-Garcia","year":"2018","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.ijcard.2025.132986_bb0050","doi-asserted-by":"crossref","first-page":"2736","DOI":"10.1161\/CIRCULATIONAHA.110.009449","article-title":"Standardized bleeding definitions for cardiovascular clinical trials: a consensus report from the bleeding academic research consortium","volume":"123","author":"Mehran","year":"2011","journal-title":"Circulation"},{"key":"10.1016\/j.ijcard.2025.132986_bb0055","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCINTERVENTIONS.114.001645","article-title":"Access and non-access site bleeding after percutaneous coronary intervention and risk of subsequent mortality and major adverse cardiovascular events: systematic review and meta-analysis","volume":"8","author":"Kwok","year":"2015","journal-title":"Circ. Cardiovasc. Interv."},{"key":"10.1016\/j.ijcard.2025.132986_bb0060","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/j.jcin.2010.10.011","article-title":"Incidence, prognostic impact, and influence of antithrombotic therapy on access and nonaccess site bleeding in percutaneous coronary intervention","volume":"4","author":"Verheugt","year":"2011","journal-title":"JACC Cardiovasc. Interv."},{"key":"10.1016\/j.ijcard.2025.132986_bb0065","doi-asserted-by":"crossref","first-page":"71","DOI":"10.4244\/EIJV8I1A12","article-title":"Does the site of bleeding matter? A stratified analysis on location of TIMI-graded bleedings and their impact on 12-month outcome in patients with ST-segment elevation myocardial infarction","volume":"8","author":"Vranckx","year":"2012","journal-title":"EuroIntervention"},{"key":"10.1016\/j.ijcard.2025.132986_bb0070","doi-asserted-by":"crossref","DOI":"10.3389\/fcvm.2021.620354","article-title":"Ischemic and bleeding outcomes according to the academic research consortium high bleeding risk criteria in all comers treated by percutaneous coronary interventions","volume":"8","author":"Doomun","year":"2021","journal-title":"Front. Cardiovasc. Med."},{"key":"10.1016\/j.ijcard.2025.132986_bb0075","doi-asserted-by":"crossref","first-page":"3743","DOI":"10.1093\/eurheartj\/ehaa671","article-title":"Validation of high bleeding risk criteria and definition as proposed by the academic research consortiumfor high bleeding risk","volume":"41","author":"Corpataux","year":"2020","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.ijcard.2025.132986_bb0080","doi-asserted-by":"crossref","first-page":"1560","DOI":"10.1253\/circj.CJ-20-0395","article-title":"Prevalence of the academic research consortium for high bleeding risk criteria and prognostic value of a simplified definition","volume":"84","author":"Miura","year":"2020","journal-title":"Circ. J."},{"key":"10.1016\/j.ijcard.2025.132986_bb0085","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1161\/CIRCULATIONAHA.119.041619","article-title":"Long-term safety and efficacy of durable polymer cobalt-chromium everolimus-eluting stents in patients at high bleeding risk: a patient-level stratified analysis from four Postapproval studies","volume":"141","author":"Sorrentino","year":"2020","journal-title":"Circulation"},{"key":"10.1016\/j.ijcard.2025.132986_bb0090","first-page":"361","article-title":"Increased cardiovascular risk in rheumatoid arthritis: mechanisms and implications","author":"England","year":"2018","journal-title":"BMJ"},{"key":"10.1016\/j.ijcard.2025.132986_bb0095","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0281067","article-title":"Clinical outcomes of patients with rheumatoid arthritis who underwent percutaneous coronary intervention: a Korean nationwide cohort study","volume":"18","author":"Ha","year":"2023","journal-title":"PLoS ONE"},{"key":"10.1016\/j.ijcard.2025.132986_bb0100","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1378\/chest.10-2644","article-title":"Increased adverse events after percutaneous coronary intervention in patients with COPD: insights from the National Heart, Lung, and Blood Institute dynamic registry","volume":"140","author":"Enriquez","year":"2011","journal-title":"Chest"},{"key":"10.1016\/j.ijcard.2025.132986_bb0105","doi-asserted-by":"crossref","first-page":"1685","DOI":"10.1056\/NEJMra043430","article-title":"Inflammation, atherosclerosis, and coronary artery disease","volume":"352","author":"Hansson","year":"2005","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ijcard.2025.132986_bb0110","doi-asserted-by":"crossref","first-page":"1643","DOI":"10.1056\/NEJMoa2108749","article-title":"Dual antiplatelet therapy after PCI in patients at high bleeding risk","volume":"385","author":"Valgimigli","year":"2021","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ijcard.2025.132986_bb0115","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1001\/jamacardio.2021.5244","article-title":"Comparison of Clopidogrel monotherapy after 1 to 2 months of dual antiplatelet therapy with 12 months of dual antiplatelet therapy in patients with acute coronary syndrome: the STOPDAPT-2 ACS randomized clinical trial","volume":"7","author":"Watanabe","year":"2022","journal-title":"JAMA Cardiol."},{"key":"10.1016\/j.ijcard.2025.132986_bb0120","doi-asserted-by":"crossref","first-page":"1866","DOI":"10.1016\/S0140-6736(24)00473-2","article-title":"Ticagrelor alone versus ticagrelor plus aspirin from month 1 to month 12 after percutaneous coronary intervention in patients with acute coronary syndromes (ULTIMATE-DAPT): a randomised, placebo-controlled, double-blind clinical trial","volume":"403","author":"Ge","year":"2024","journal-title":"Lancet"},{"key":"10.1016\/j.ijcard.2025.132986_bb0125","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.124.034709","article-title":"Abbreviated versus standard dual antiplatelet therapy times after percutaneous coronary intervention in patients with high bleeding risk with acute coronary syndrome: insights from the SWEDEHEART registry","volume":"13","author":"H\u00e5kansson","year":"2024","journal-title":"J. Am. Heart Assoc."}],"container-title":["International Journal of Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0167527325000294?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0167527325000294?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,13]],"date-time":"2026-05-13T00:03:44Z","timestamp":1778630624000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0167527325000294"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3]]},"references-count":25,"alternative-id":["S0167527325000294"],"URL":"https:\/\/doi.org\/10.1016\/j.ijcard.2025.132986","relation":{},"ISSN":["0167-5273"],"issn-type":[{"value":"0167-5273","type":"print"}],"subject":[],"published":{"date-parts":[[2025,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Impact of high bleeding risk and associated risk factors on major adverse cardiovascular or cerebrovascular events in primary percutaneous coronary intervention treated ST-elevation myocardial infarction","name":"articletitle","label":"Article Title"},{"value":"International Journal of Cardiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijcard.2025.132986","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"132986"}}